Abstract
Inborn errors of metabolism (IEM) comprise a large class of recessive genetic diseases involving disorders of cellular metabolism that tend to be caused by missense mutations in which a single incorrect amino acid is substituted in the polypeptide chain. Cystathionine beta-synthase (CBS) deficiency is an example of an IEM that causes large elevations of blood total homocysteine levels, resulting in phenotypes in several tissues. Current treatment strategies involve dietary restriction and vitamin therapy, but these are only partially effective and do not work in all patients. Over 85% of the described mutations in CBS-deficient patients are missense mutations in which the mutant protein fails to fold into an active conformation. The ability of CBS to achieve an active conformation is affected by a variety of intracellular protein networks including the chaperone system and the ubiquitin/proteasome system, collectively referred to as the proteostasis network. Proteostasis modulators are drugs that perturb various aspects of these networks. In this article, we will review the evidence that modulation of the intracellular protein folding environment can be used as a potential therapeutic strategy to treat CBS deficiency and discuss the pros and cons of such a strategy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Applegarth DA, Toone JR, Lowry RB (2000) Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics 105:e10. https://doi.org/10.1542/peds.105.1.e10
Aral B, Coude M, London J, Aupetit J, Chasse JF, Zabot MT, Chadefaux-Vekemans B, Kamoun P (1997) Two novel mutations (K384E and L539S) in the C-terminal moiety of the cystathionine beta-synthase protein in two French pyridoxine-responsive homocystinuria patients. Hum Mutat 9:81–82. https://doi.org/10.1002/(SICI)1098-1004(1997)9:1%3c81::AID-HUMU18%3e3.0.CO;2-L
Balch WE, Morimoto RI, Dillin A, Kelly JW (2008) Adapting proteostasis for disease intervention. Science 319:916–919. https://doi.org/10.1126/science.1141448
Banerjee R, Zou CG (2005) Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys 433:144–156. https://doi.org/10.1016/j.abb.2004.08.037
Barber GW, Spaeth GL (1969) The successful treatment of homocystinuria with pyridoxine. J Pediatr 75:463–478. https://doi.org/10.1016/s0022-3476(69)80274-x
Bross P, Corydon TJ, Andresen BS, Jorgensen MM, Bolund L, Gregersen N (1999) Protein misfolding and degradation in genetic diseases. Hum Mutat 14:186–198. https://doi.org/10.1002/(SICI)1098-1004(1999)14:3%3c186::AID-HUMU2%3e3.0.CO;2-J
Carson NA, Carre IJ (1969) Treatment of homocystinuria with pyridoxine. A preliminary study. Arch Dis Child 44:387–392. https://doi.org/10.1136/adc.44.235.387
Chen X, Wang L, Fazlieva R, Kruger WD (2006) Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response. Hum Mutat 27:474–482. https://doi.org/10.1002/humu.20320
de Franchis R, Kraus E, Kozich V, Sebastio G, Kraus JP (1999) Four novel mutations in the cystathionine beta-synthase gene: effect of a second linked mutation on the severity of the homocystinuric phenotype. Hum Mutat 13:453–457. https://doi.org/10.1002/(SICI)1098-1004(1999)13:6%3c453::AID-HUMU4%3e3.0.CO;2-K
DePristo MA, Weinreich DM, Hartl DL (2005) Missense meanderings in sequence space: a biophysical view of protein evolution. Nat Rev Genet 6:678–687. https://doi.org/10.1038/nrg1672
Ereno-Orbea J, Majtan T, Oyenarte I, Kraus JP, Martinez-Cruz LA (2013) Structural basis of regulation and oligomerization of human cystathionine beta-synthase, the central enzyme of transsulfuration. Proc Natl Acad Sci USA 110:E3790–E3799. https://doi.org/10.1073/pnas.1313683110
Ereno-Orbea J, Majtan T, Oyenarte I, Kraus JP, Martinez-Cruz LA (2014) Structural insight into the molecular mechanism of allosteric activation of human cystathionine beta-synthase by S-adenosylmethionine. Proc Natl Acad Sci USA 111:E3845–E3852. https://doi.org/10.1073/pnas.1414545111
Fowler B, Kraus J, Packman S, Rosenberg LE (1978) Homocystinuria. Evidence for three distinct classes of cystathionine beta-synthase mutants in cultured fibroblasts. J Clin Investig 61:645–653. https://doi.org/10.1172/JCI108976
Gaustadnes M, Rudiger N, Rasmussen K, Ingerslev J (2000) Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants. Thromb Haemost 83:554–558
Gaustadnes M, Wilcken B, Oliveriusova J, McGill J, Fletcher J, Kraus JP, Wilcken DE (2002) The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment. Hum Mutat 20:117–126. https://doi.org/10.1002/humu.10104
Gupta S, Wang L, Hua X, Krijt J, Kozich V, Kruger WD (2008) Cystathionine β-synthase p. S466L mutation causes hyperhomocysteinemia in mice. Hum Mutat 29:1048–1054. https://doi.org/10.1002/humu.20773
Gupta S, Wang L, Anderl J, Slifker MJ, Kirk C, Kruger WD (2013) Correction of cystathionine beta-synthase deficiency in mice by treatment with proteasome inhibitors. Hum Mutat 34:1085–1093. https://doi.org/10.1002/humu.22335
Gupta S, Kelow S, Wang L, Andrake M, Dunbrack RL Jr, Kruger WD (2018) Mouse modeling and structural analysis of the p. G307S mutation in human cystathionine beta-synthase (CBS) reveal effects on CBS activity but not stability. J Biol Chem 293:13921–13931. https://doi.org/10.1074/jbc.RA118.002164
Gupta S, Gallego-Villar L, Wang L, Lee HO, Nasrallah G, Al-Dewik N, Haberle J, Thony B, Blom HJ, Ben-Omran T, Kruger WD (2019) Analysis of the Qatari R336C cystathionine beta-synthase protein in mice. J Inherit Metab Dis 42:831–838. https://doi.org/10.1002/jimd.12140
Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE (1993) Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 2:1857–1860. https://doi.org/10.1093/hmg/2.11.1857
Ignoul S, Eggermont J (2005) CBS domains: structure, function, and pathology in human proteins. Am J Physiol Cell Physiol 289:C1369–C1378. https://doi.org/10.1152/ajpcell.00282.2005
Janoik M, Sokolova J, Janosikova B, Krijt J, Klatovska V, Kozich V (2009) Birth prevalence of homocystinuria in central europe: frequency and pathogenicity of mutation c.1105C > T (p. R369C) in the cystathionine beta-synthase gene. J Pediatr 154:431–437. https://doi.org/10.1016/j.jpeds.2008.09.015
Janosik M, Kery V, Gaustadnes M, Maclean KN, Kraus JP (2001a) Regulation of human cystathionine beta-synthase by S-adenosyl-l-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry 40:10625–10633. https://doi.org/10.1021/bi010711p
Janosik M, Oliveriusova J, Janosikova B, Sokolova J, Kraus E, Kraus JP, Kozich V (2001b) Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria. Am J Hum Genet 68:1506–1513. https://doi.org/10.1086/320597
Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, Burnstock G, Greensmith L (2004) Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 10:402–405. https://doi.org/10.1038/nm1021
Kim D, Li GC (1999) Proteasome inhibitors lactacystin and MG132 inhibit the dephosphorylation of HSF1 after heat shock and suppress thermal induction of heat shock gene expression. Biochem Biophys Res Commun 264:352–358. https://doi.org/10.1006/bbrc.1999.1371
Kim CE, Gallagher PM, Guttormsen AB, Refsum H, Ueland PM, Ose L, Folling I, Whitehead AS, Tsai MY, Kruger WD (1997) Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet 6:2213–2221. https://doi.org/10.1093/hmg/6.13.2213
Kluijtmans LA, Boers GH, Stevens EM, Renier WO, Kraus JP, Trijbels FJ, van den Heuvel LP, Blom HJ (1996) Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Investig 98:285–289. https://doi.org/10.1172/JCI118791
Kluijtmans LA, Boers GH, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, Blom HJ (1999) The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet 65:59–67. https://doi.org/10.1086/302439
Kopecka J, Krijt J, Rakova K, Kozich V (2011) Restoring assembly and activity of cystathionine beta-synthase mutants by ligands and chemical chaperones. J Inherit Metab Dis 34:39–48. https://doi.org/10.1007/s10545-010-9087-5
Kozich V, Kraus JP (1992) Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency. Hum Mutat 1:113–123. https://doi.org/10.1002/humu.1380010206
Kraus J, Packman S, Fowler B, Rosenberg LE (1978) Purification and properties of cystathionine beta-synthase from human liver. Evidence for identical subunits. J Biol Chem 253:6523–6528
Kruger WD, Cox DR (1994) A yeast system for expression of human cystathionine beta-synthase: structual and functional conservation of the human and yeast genes. Proc Natl Acad Sci USA 91:6614–6618. https://doi.org/10.1073/pnas.91.14.6614
Kruger WD, Wang L, Jhee KH, Singh RH, Elsas LJ 2nd (2003) Cystathionine beta-synthase deficiency in Georgia (USA): correlation of clinical and biochemical phenotype with genotype. Hum Mutat 22:434–441. https://doi.org/10.1002/humu.10290
Leandro P, Gomes CM (2008) Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning. Mini Rev Med Chem 8:901–911. https://doi.org/10.2174/138955708785132783
Lee DH, Goldberg AL (1998) Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae. Mol Cell Biol 18:30–38. https://doi.org/10.1128/MCB.18.1.30
Lee HO, Gallego-Villar L, Grisch-Chan HM, Haberle J, Thony B, Kruger WD (2019) Treatment of cystathionine beta-synthase deficiency in mice using a minicircle-based naked DNA vector. Hum Gene Ther 30:1093–1100. https://doi.org/10.1089/hum.2019.014
Maclean KN, Gaustadnes M, Oliveriusova J, Janosik M, Kraus E, Kozich V, Kery V, Skovby F, Rudiger N, Ingerslev J, Stabler SP, Allen RH, Kraus JP (2002) High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations. Hum Mutat 19:641–655. https://doi.org/10.1002/humu.10089
Majtan T, Singh LR, Wang L, Kruger WD, Kraus JP (2008) Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone. J Biol Chem 283:34588–34595. https://doi.org/10.1074/jbc.M805928200
Majtan T, Liu L, Carpenter JF, Kraus JP (2010) Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: purification and characterization of eight CBS mutant enzymes. J Biol Chem 285:15866–15873. https://doi.org/10.1074/jbc.M110.107722
Majtan T, Freeman KM, Smith AT, Burstyn JN, Kraus JP (2011) Purification and characterization of cystathionine beta-synthase bearing a cobalt protoporphyrin. Arch Biochem Biophys 508:25–30. https://doi.org/10.1016/j.abb.2011.01.012
Majtan T, Jones W Jr, Krijt J, Park I, Kruger WD, Kozich V, Bassnett S, Bublil EM, Kraus JP (2018) Enzyme replacement therapy ameliorates multiple symptoms of murine homocystinuria. Mol Ther 26:834–844. https://doi.org/10.1016/j.ymthe.2017.12.014
Melenovska P, Kopecka J, Krijt J, Hnizda A, Rakova K, Janosik M, Wilcken B, Kozich V (2015) Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate. J Inherit Metab Dis 38:287–294. https://doi.org/10.1007/s10545-014-9781-9
Morello JP, Petaja-Repo UE, Bichet DG, Bouvier M (2000) Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 21:466–469. https://doi.org/10.1016/s0165-6147(00)01575-3
Morris AA, Kozich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, Crushell E, Henderson MJ, Hochuli M, Huemer M, Janssen MC, Maillot F, Mayne PD, McNulty J, Morrison TM, Ogier H, O’Sullivan S, Pavlikova M, de Almeida IT, Terry A, Yap S, Blom HJ, Chapman KA (2017) Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis 40:49–74. https://doi.org/10.1007/s10545-016-9979-0
Morrison T, Bosch F, Landolt MA, Kozich V, Huemer M, Morris AAM (2021) Homocystinuria patient and caregiver survey: experiences of diagnosis and patient satisfaction. Orphanet J Rare Dis 16:124. https://doi.org/10.1186/s13023-021-01764-x
Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R et al (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1–31
Mudd SH, Levy HL, Kraus JP (2001) Disorders in transsulfuration. In: Scriver CR, Beaudet A, Sly W, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 2007–2056
Oliveriusova J, Kery V, Maclean KN, Kraus JP (2002) Deletion mutagenesis of human cystathionine beta-synthase. Impact on activity, oligomeric status, and S-adenosylmethionine regulation. J Biol Chem 277:48386–48394. https://doi.org/10.1074/jbc.M207087200
Ong DS, Mu TW, Palmer AE, Kelly JW (2010) Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol 6:424–432. https://doi.org/10.1038/nchembio.368
Orlowski RZ, Kuhn DJ (2008) Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 14:1649–1657. https://doi.org/10.1158/1078-0432.CCR-07-2218
Poloni S, Sperb-Ludwig F, Borsatto T, Weber Hoss G, Doriqui MJR, Embirucu EK, Boa-Sorte N, Marques C, Kim CA, Moura F, de Souza C, Rocha H, Ribeiro M, Steiner CE, Moreno CA, Bernardi P, Valadares E, Artigalas O, Carvalho G, Wanderley HYC, Kugele J, Walter M, Gallego-Villar L, Blom HJ, Schwartz IVD (2018) CBS mutations are good predictors for B6-responsiveness: a study based on the analysis of 35 Brazilian classical homocystinuria patients. Mol Genet Genom Med 6:160–170. https://doi.org/10.1002/mgg3.342
Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78:959–991. https://doi.org/10.1146/annurev.biochem.052308.114844
Seashore MR, Durant JL, Rosenberg LE (1972) Studies of the mechanism of pyridoxine-responsive homocystinuria. Pediatr Res 6:187–196. https://doi.org/10.1203/00006450-197203000-00007
Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G (1995) The molecular basis of homocystinuria due to cystathionine beta synthase deficiency in italian families, and report of four novel mutations. Am J Hum Genet 56:1324–1333
Seemann S, Ernst M, Cimmaruta C, Struckmann S, Cozma C, Koczan D, Knospe AM, Haake LR, Citro V, Brauer AU, Andreotti G, Cubellis MV, Fuellen G, Hermann A, Giese AK, Rolfs A, Lukas J (2020) Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease. Biochem J 477:359–380. https://doi.org/10.1042/BCJ20190513
Shan X, Kruger WD (1998) Correction of disease-causing CBS mutations in yeast. Nat Genet 19:91–93. https://doi.org/10.1038/ng0598-91
Shan X, Dunbrack RL Jr, Christopher SA, Kruger WD (2001) Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis. Hum Mol Genet 10:635–643. https://doi.org/10.1093/hmg/10.6.635
Singh LR, Chen X, Kozich V, Kruger WD (2007) Chemical chaperone rescue of mutant human cystathionine β-synthase. Mol Genet Metab 91:335–342. https://doi.org/10.1016/j.ymgme.2007.04.011
Singh LR, Gupta S, Honig NH, Kraus JP, Kruger WD (2010) Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PLoS Genet 6:e1000807. https://doi.org/10.1371/journal.pgen.1000807
Singh LR, Kruger WD (2009) Functional rescue of mutant human cystathionine β-synthase by manipulation of Hsp26 and Hsp70 levels in Saccharomyces cerevisiae. J Biol Chem 284:4238–4245. https://doi.org/10.1074/jbc.M806387200
Smith AT, Majtan T, Freeman KM, Su Y, Kraus JP, Burstyn JN (2011) Cobalt cystathionine beta-synthase: a cobalt-substituted heme protein with a unique thiolate ligation motif. Inorg Chem 50:4417–4427. https://doi.org/10.1021/ic102586b
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human gene mutation database (HGMD): 2003 update. Hum Mutat 21:577–581. https://doi.org/10.1002/humu.10212
Taoka S, Ohja S, Shan X, Kruger WD, Banerjee R (1998) Evidence for heme-mediated redox regulation of human cystathionine beta-synthase activity. J Biol Chem 273:25179–25184. https://doi.org/10.1074/jbc.273.39.25179
Taoka S, Lepore BW, Kabil O, Ojha S, Ringe D, Banerjee R (2002) Human cystathionine beta-synthase is a heme sensor protein. Evidence that the redox sensor is heme and not the vicinal cysteines in the CXXC motif seen in the crystal structure of the truncated enzyme. Biochemistry 41:10454–10461. https://doi.org/10.1021/bi026052d
Weber Hoss GR, Sperb-Ludwig F, Schwartz IVD, Blom HJ (2020) Classical homocystinuria: a common inborn error of metabolism? An epidemiological study based on genetic databases. Mol Genet Genomic Med 8:e1214. https://doi.org/10.1002/mgg3.1214
Yang C, Huntoon K, Ksendzovsky A, Zhuang Z, Lonser RR (2013) Proteostasis modulators prolong missense VHL protein activity and halt tumor progression. Cell Rep 3:52–59. https://doi.org/10.1016/j.celrep.2012.12.007
Funding
This work was funded by a grant from by grant DK101404 from the National Institutes of Health, and an appropriation from the Commonwealth of Pennsylvania.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kruger, W.D. How to fix a broken protein: restoring function to mutant human cystathionine β-synthase. Hum Genet 141, 1299–1308 (2022). https://doi.org/10.1007/s00439-021-02386-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-021-02386-w